Cost and Access Implications of Defining CAR-T Therapy as a Drug

Saved in:
Bibliographic Details
Published in:JAMA health forum 2020-07, Vol.1 (7), p.e200868-e200868
Main Authors: Chalasani, Rohan, Hershey, Tina B., Gellad, Walid F.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403
cites cdi_FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403
container_end_page e200868
container_issue 7
container_start_page e200868
container_title JAMA health forum
container_volume 1
creator Chalasani, Rohan
Hershey, Tina B.
Gellad, Walid F.
description
doi_str_mv 10.1001/jamahealthforum.2020.0868
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2723815906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2666967923</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403</originalsourceid><addsrcrecordid>eNpdkD1rwzAURUVpoSHNf1Dp0sWpnmxL8tbg9CMQKLTZxYssJQ625Ur2kH_fhHYome4dDpfLIeQe2BwYg6cDtri32Ax758PYzjnjbM6UUFdkwoUqEgZKXP_rt2QW44ExxnMAIdMJeS59HCh2FV0YY2Okq7ZvaoND7btIvaNL6-qu7na0XHwmG7rZ24D9kWKkSJdh3N2RG4dNtLO_nJKv15dN-Z6sP95W5WKdGA5KJTIDmxtTyLwS2bYqBBMOZQ7OVSlaBJCZcyozEtBu1ZZVijuRA5qscBlLp-Txd7UP_nu0cdBtHY1tGuysH6PmkqcK8oKJE_pwgR78GLrTN82FEIWQBU9PVPFLmeBjDNbpPtQthqMGps9y9YVcfZarz3LTH3yycAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2666967923</pqid></control><display><type>article</type><title>Cost and Access Implications of Defining CAR-T Therapy as a Drug</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Chalasani, Rohan ; Hershey, Tina B. ; Gellad, Walid F.</creator><creatorcontrib>Chalasani, Rohan ; Hershey, Tina B. ; Gellad, Walid F.</creatorcontrib><identifier>ISSN: 2689-0186</identifier><identifier>EISSN: 2689-0186</identifier><identifier>DOI: 10.1001/jamahealthforum.2020.0868</identifier><language>eng</language><publisher>Chicago: American Medical Association</publisher><ispartof>JAMA health forum, 2020-07, Vol.1 (7), p.e200868-e200868</ispartof><rights>2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403</citedby><cites>FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2666967923?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25751,27922,27923,37010,37011,44588</link.rule.ids></links><search><creatorcontrib>Chalasani, Rohan</creatorcontrib><creatorcontrib>Hershey, Tina B.</creatorcontrib><creatorcontrib>Gellad, Walid F.</creatorcontrib><title>Cost and Access Implications of Defining CAR-T Therapy as a Drug</title><title>JAMA health forum</title><issn>2689-0186</issn><issn>2689-0186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkD1rwzAURUVpoSHNf1Dp0sWpnmxL8tbg9CMQKLTZxYssJQ625Ur2kH_fhHYome4dDpfLIeQe2BwYg6cDtri32Ax758PYzjnjbM6UUFdkwoUqEgZKXP_rt2QW44ExxnMAIdMJeS59HCh2FV0YY2Okq7ZvaoND7btIvaNL6-qu7na0XHwmG7rZ24D9kWKkSJdh3N2RG4dNtLO_nJKv15dN-Z6sP95W5WKdGA5KJTIDmxtTyLwS2bYqBBMOZQ7OVSlaBJCZcyozEtBu1ZZVijuRA5qscBlLp-Txd7UP_nu0cdBtHY1tGuysH6PmkqcK8oKJE_pwgR78GLrTN82FEIWQBU9PVPFLmeBjDNbpPtQthqMGps9y9YVcfZarz3LTH3yycAw</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Chalasani, Rohan</creator><creator>Hershey, Tina B.</creator><creator>Gellad, Walid F.</creator><general>American Medical Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M0T</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>Cost and Access Implications of Defining CAR-T Therapy as a Drug</title><author>Chalasani, Rohan ; Hershey, Tina B. ; Gellad, Walid F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chalasani, Rohan</creatorcontrib><creatorcontrib>Hershey, Tina B.</creatorcontrib><creatorcontrib>Gellad, Walid F.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Health Management Database (Proquest)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA health forum</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chalasani, Rohan</au><au>Hershey, Tina B.</au><au>Gellad, Walid F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost and Access Implications of Defining CAR-T Therapy as a Drug</atitle><jtitle>JAMA health forum</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>1</volume><issue>7</issue><spage>e200868</spage><epage>e200868</epage><pages>e200868-e200868</pages><issn>2689-0186</issn><eissn>2689-0186</eissn><cop>Chicago</cop><pub>American Medical Association</pub><doi>10.1001/jamahealthforum.2020.0868</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2689-0186
ispartof JAMA health forum, 2020-07, Vol.1 (7), p.e200868-e200868
issn 2689-0186
2689-0186
language eng
recordid cdi_proquest_miscellaneous_2723815906
source Publicly Available Content Database (Proquest) (PQ_SDU_P3)
title Cost and Access Implications of Defining CAR-T Therapy as a Drug
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%20and%20Access%20Implications%20of%20Defining%20CAR-T%20Therapy%20as%20a%20Drug&rft.jtitle=JAMA%20health%20forum&rft.au=Chalasani,%20Rohan&rft.date=2020-07-01&rft.volume=1&rft.issue=7&rft.spage=e200868&rft.epage=e200868&rft.pages=e200868-e200868&rft.issn=2689-0186&rft.eissn=2689-0186&rft_id=info:doi/10.1001/jamahealthforum.2020.0868&rft_dat=%3Cproquest_cross%3E2666967923%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2188-741e5cc975d64bd9606fa751ffd3aea1174ff84c71aeb8b0d82f651ac49f403%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2666967923&rft_id=info:pmid/&rfr_iscdi=true